Search Results

NxStage PureFlow Solution is indicated for use with NxStage renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis for chronic care patients.

The NxStage PureFlow Solution is a family of premixed dialysate solution formulations which are sterile, non-pyrogenic, fully constituted dialysate solutions provided in 5L single use flexible bags.

The provided text describes the 510(k) premarket notification for the NxStage PureFlow Solution, a pre-mixed dialysate for hemodialysis. However, the document does not contain information about a study involving an AI/Machine Learning device or a Multi-Reader Multi-Case (MRMC) comparative effectiveness study.

The document discusses performance testing for the NxStage PureFlow Solution, which is a physical medical device (a liquid solution in a bag), not a software or AI-driven diagnostic device. Therefore, the acceptance criteria and study details requested in the prompt (e.g., sample size for test/training sets, data provenance, expert ground truth, adjudication methods, MRMC studies, standalone algorithm performance) are not applicable to the content of this document.

The performance data mentioned in the document for the NxStage PureFlow Solution are related to:

• Analytical testing: per device specifications and applicable sections of USP and EP.
• Physical testing of container (bag): per device specifications.
• Container closure integrity testing: per ISO 11607-1.
• Temperature excursion testing: per device specifications.
• Stability/Shelf-life testing: per ICH Q1A to support a 24-month shelf life.
• Ship testing: per ASTM D4169-22.
• Biocompatibility testing: in accordance with ISO 10993-1 and FDA guidance, including chemical characterization, toxicological risk assessment, cytotoxicity, sensitization, irritation, pyrogenicity, hemocompatibility, and systemic toxicity.
• Human Factors Validation Testing: in accordance with FDA guidance and AAMI/ANSI/EC 62366-1.
• Electrical Safety and EMC: Not Applicable (the device has no electronic features).
• Software Verification and Validation Testing: Not Applicable (the device has no software features).
• Animal Studies: Not Applicable.
• Clinical Studies: Not Applicable.

The conclusion states that "Verification and validation was conducted to characterize the proposed device and the predetermined acceptance criteria were met." However, the document does not enumerate specific quantitative acceptance criteria or the specific performance metrics achieved in these tests, only the types of tests conducted.

Therefore, I cannot provide the requested information about AI acceptance criteria and study details based on the provided document.

Ask a specific question about this device